These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 21892695)
21. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation. Freag MS; Elnaggar YS; Abdallah OY Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765 [TBL] [Abstract][Full Text] [Related]
22. Preparation and in vitro/in vivo evaluation of felodipine nanosuspension. Sahu BP; Das MK Eur J Drug Metab Pharmacokinet; 2014 Sep; 39(3):183-93. PubMed ID: 24198215 [TBL] [Abstract][Full Text] [Related]
23. Formulation, evaluation and optimization of the felodipine nanosuspension to be used for direct compression to tablet for in vitro dissolution enhancement. Mori D; Makwana J; Parmar R; Patel K; Chavda J Pak J Pharm Sci; 2016 Nov; 29(6):1927-1936. PubMed ID: 28375107 [TBL] [Abstract][Full Text] [Related]
24. Development of nitrendipine controlled release formulations based on SLN and NLC for topical delivery: in vitro and ex vivo characterization. Bhaskar K; Krishna Mohan C; Lingam M; Prabhakar Reddy V; Venkateswarlu V; Madhusudan Rao Y Drug Dev Ind Pharm; 2008 Jul; 34(7):719-25. PubMed ID: 18612912 [TBL] [Abstract][Full Text] [Related]
25. Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method. Shi-Ying J; Jin H; Shi-Xiao J; Qing-Yuan L; Jin-Xia B; Chen HG; Rui-Sheng L; Wei W; Hai-Long Y Chin J Nat Med; 2014 Jan; 12(1):71-80. PubMed ID: 24484600 [TBL] [Abstract][Full Text] [Related]
26. Preparation and evaluation of solid dispersion for nitrendipine-carbopol and nitrendipine-HPMCP systems using a twin screw extruder. Wang L; Cui FD; Hayase T; Sunada H Chem Pharm Bull (Tokyo); 2005 Oct; 53(10):1240-5. PubMed ID: 16204977 [TBL] [Abstract][Full Text] [Related]
27. Preparation, characterization and in vivo assessment of the bioavailability of glycyrrhizic acid microparticles by supercritical anti-solvent process. Sui X; Wei W; Yang L; Zu Y; Zhao C; Zhang L; Yang F; Zhang Z Int J Pharm; 2012 Feb; 423(2):471-9. PubMed ID: 22183131 [TBL] [Abstract][Full Text] [Related]
28. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery. Kumar BS; Saraswathi R; Kumar KV; Jha SK; Venkates DP; Dhanaraj SA Drug Deliv; 2014 May; 21(3):173-84. PubMed ID: 24102185 [TBL] [Abstract][Full Text] [Related]
29. The role of pharmacokinetic modelling and computer simulation in drug formulation design. Grabnar I; Belic A; Mrhar A; Karba R Comput Biol Med; 1998 Jul; 28(4):365-76. PubMed ID: 9805197 [TBL] [Abstract][Full Text] [Related]
30. Engineering of solidified glyburide nanocrystals for tablet formulation via loading of carriers: downstream processing, characterization, and bioavailability. Ali HSM; Hanafy AF; Alqurshi A Int J Nanomedicine; 2019; 14():1893-1906. PubMed ID: 30936692 [TBL] [Abstract][Full Text] [Related]
31. Development of isradipine loaded self-nano emulsifying powders for improved oral delivery: in vitro and in vivo evaluation. Ramasahayam B; Eedara BB; Kandadi P; Jukanti R; Bandari S Drug Dev Ind Pharm; 2015 May; 41(5):753-63. PubMed ID: 24641324 [TBL] [Abstract][Full Text] [Related]
32. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying. Hu J; Ng WK; Dong Y; Shen S; Tan RB Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643 [TBL] [Abstract][Full Text] [Related]
33. Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using box-behnken statistical design. Sharma A; Singh AP; Harikumar SL Drug Dev Ind Pharm; 2020 Feb; 46(2):329-342. PubMed ID: 31976777 [No Abstract] [Full Text] [Related]
34. Design of sustained-release nitrendipine microspheres having solid dispersion structure by quasi-emulsion solvent diffusion method. Cui F; Yang M; Jiang Y; Cun D; Lin W; Fan Y; Kawashima Y J Control Release; 2003 Sep; 91(3):375-84. PubMed ID: 12932715 [TBL] [Abstract][Full Text] [Related]
35. Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets. Salazar J; Müller RH; Möschwitzer JP Eur J Pharm Sci; 2013 Jul; 49(4):565-77. PubMed ID: 23587645 [TBL] [Abstract][Full Text] [Related]
36. Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol. Miao X; Sun C; Jiang T; Zheng L; Wang T; Wang S J Pharm Pharm Sci; 2011; 14(2):196-214. PubMed ID: 21733409 [TBL] [Abstract][Full Text] [Related]
37. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process. Ha ES; Kim JS; Baek IH; Yoo JW; Jung Y; Moon HR; Kim MS Drug Des Devel Ther; 2015; 9():4269-77. PubMed ID: 26345723 [TBL] [Abstract][Full Text] [Related]
38. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Hecq J; Deleers M; Fanara D; Vranckx H; Amighi K Int J Pharm; 2005 Aug; 299(1-2):167-77. PubMed ID: 15996838 [TBL] [Abstract][Full Text] [Related]
39. In vitro/in vivo evaluation of felodipine micropowders prepared by the wet-milling process combined with different solidification methods. Meng J; Li S; Yao Q; Zhang L; Weng Y; Cai C; Xu H; Tang X Drug Dev Ind Pharm; 2014 Jul; 40(7):929-36. PubMed ID: 23614872 [TBL] [Abstract][Full Text] [Related]
40. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose. Yi T; Wan J; Xu H; Yang X Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]